A family history questionnaire improves detection of women at risk for hereditary gynecologic cancer: A pilot study

Familial Cancer

Volumn 13, Issue 3, 2014, Pages 469-475

  Koeneman, Margot M ^a,b   Kruse, Arnold Jan ^a,b   Sep, Simone J S ^a   Gubbels, Cynthia S ^a   Slangen, Brigitte F M ^a,b   Van Gorp, Toon ^a,b   Lopes, Alberto ^c   Gomez Garcia, Encarna ^a,b   Kruitwagen, Roy F P M ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ROYAL CORNWALL HOSPITAL   (United Kingdom)

Author keywords

BRCA 1 genes; BRCA 2 genes; Gynae oncology; Hereditary nonpolyposis colorectal neoplasms; Pedigree; Questionnaires

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; BREAST CANCER; CANCER GENETIC SERVICE; CANCER RISK; CONTROLLED STUDY; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; FEMALE GENITAL TRACT CANCER; GENE MUTATION; GENETIC SERVICE; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MISMATCH REPAIR; OBSERVATIONAL STUDY; OVARY CANCER; PATIENT REFERRAL; PILOT STUDY; PROSPECTIVE STUDY; QUESTIONNAIRE; RETROSPECTIVE STUDY; ANAMNESIS; GENETIC PREDISPOSITION; GENETICS; GENITAL NEOPLASMS, FEMALE; MIDDLE AGED; PROCEDURES;

ADULT; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENITAL NEOPLASMS, FEMALE; HUMANS; MEDICAL HISTORY TAKING; MIDDLE AGED; PILOT PROJECTS; QUESTIONNAIRES; REFERRAL AND CONSULTATION;

EID: 84907172170     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-014-9711-x     Document Type: Article

References (26)

1. Lu KH (2008) Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis. Fam Cancer 7(1):53-58
2. Meyer LA, Broaddus RR, Lu KH (2009) Endometrial cancer and lynch syndrome: clinical and pathologic considerations. Cancer Control 16(1):14-22
3. Lancaster JM, Powell CB, Kauff ND, Cass I, Chen LM, Lu KH, Mutch DG, Berchuck A, Karlan BY, Herzog TJ (2007) Society of Gynecologic Oncologists Education Committee statement on risk assessment for inherited gynecologic cancer predispositions. Gynecol Oncol 107(2):159-162
4. Dinh TA, Rosner BI, Atwood JC, Boland CR, Syngal S, Vasen HF, Gruber SB, Burt RW (2011) Health benefits and cost-effectiveness of primary genetic screening for lynch syndrome in the general population. Cancer Prev Res (Phila) 4(1):9-22
5. Teng I, Spigelman A (2013) Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing. Fam Cancer. doi: 10.1007/s10689-013-9695-y
6. Marquez-Rodas I, Lopez-Trabada D, Ruperez Blanco AB, Custodio Cabello S, Peligros Gomez MI, Orera Clemente M, Calvo FA, Martin M (2012) Family history record and hereditary cancer risk perception according to national cancer institute criteria in a Spanish medical oncology service: a retrospective study. Oncology 82(1):30-34
7. Lanceley A, Eagle Z, Ogden G, Gessler S, Razvi K, Ledermann JA, Side L (2012) Family history and women with ovarian cancer: is it asked and does it matter?: an observational study. Int J Gynecol Cancer 22(2):254-259
8. Grover S, Stoffel EM, Bussone L, Tschoegl E, Syngal S (2004) Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clin Gastroenterol Hepatol 2(9):813-819
9. Murff HJ, Byrne D, Syngal S (2004) Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med 27(3):239-245
10. Meyer LA, Anderson ME, Lacour RA, Suri A, Daniels MS, Urbauer DL, Nogueras-Gonzalez GM, Schmeler KM, Gershenson DM, Lu KH (2010) Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities. Obstet Gynecol 115(5):945-952
11. Bellcross CA, Kolor K, Goddard KA, Coates RJ, Reyes M, Khoury MJ (2011) Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J Prev Med 40(1):61-66
12. Reid GT, Walter FM, Brisbane JM, Emery JD (2009) Family history questionnaires designed for clinical use: a systematic review. Public Health Genomics 12(2):73-83
13. Family Medical History in Disease Prevention (2004) American Medical Association. http://www.ama-assn.org/resources/doc/genetics/family-history02.pdf
14. Scheuner MT, McNeel TS, Freedman AN (2010) Population prevalence of familial cancer and common hereditary cancer syndromes. The 2005 California health interview survey. Genet Med 12(11):726-735
15. Wallace E, Hinds A, Campbell H, Mackay J, Cetnarskyj R, Porteous ME (2004) A cross-sectional survey to estimate the prevalence of family history of colorectal, breast and ovarian cancer in a Scottish general practice population. Br J Cancer 91(8):1575-1579
16. Hughes KS, Roche C, Campbell CT, Siegel N, Salisbury L, Chekos A, Katz MS, Edell E (2003) Prevalence of family history of breast and ovarian cancer in a single primary care practice using a self-administered questionnaire. Breast J 9(1):19-25
17. Ziogas A, Horick NK, Kinney AY, Lowery JT, Domchek SM, Isaacs C, Griffin CA, Moorman PG, Edwards KL, Hill DA, Berg JS, Tomlinson GE, Anton-Culver H, Strong LC, Kasten CH, Finkelstein DM, Plon SE (2011) Clinically relevant changes in family history of cancer over time. JAMA 306(2):172-178
18. Suther S, Goodson P (2003) Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature. Genet Med 5(2):70-76
19. Mehnert A, Bergelt C, Koch U (2003) Knowledge and attitudes of gynecologists regarding genetic counseling for hereditary breast and ovarian cancer. Patient Educ Couns 49(2):183-188
20. Acton RT, Burst NM, Casebeer L, Ferguson SM, Greene P, Laird BL, Leviton L (2000) Knowledge, attitudes, and behaviors of Alabama's primary care physicians regarding cancer genetics. Acad Med 75(8):850-852
21. Schlich-Bakker KJ, ten Kroode HF, Ausems MG (2006) A literature review of the psychological impact of genetic testing on breast cancer patients. Patient Educ Couns 62(1):13-20
22. Vadaparampil ST, Miree CA, Wilson C, Jacobsen PB (2006) Psychosocial and behavioral impact of genetic counseling and testing. Breast Dis 27:97-108
23. Hopwood P (2005) Psychosocial aspects of risk communication and mutation testing in familial breast-ovarian cancer. Curr Opin Oncol 17(4):340-344
24. Ackermann S, Lux MP, Fasching PA, Strissl P, Renner SP, Poehls U, Bender HG, Beckmann MW (2006) Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers. Eur J Cancer Prev 15(6):474-479
25. Durfy SJ, Bowen DJ, McTiernan A, Sporleder J, Burke W (1999) Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev 8(4 Pt 2):369-375
26. Boulos MN, Wheeler S, Tavares C, Jones R (2011) How smartphones are changing the face of mobile and participatory healthcare: an overview, with example from eCAALYX. Biomed Eng Online 10:24